بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق

/ بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق

مروة زكريا محمد مصطفى

الموقع الشخصى

مروة زكريا محمد مصطفى

الكلية الطب - القسم طب الاطفال

الدرجات العلمية

بكالوريوس فى الطب والجراحه, -جامعة الزقازيق [2004]
ماجستير فى طب الاطفال, -جامعة الزقازيق [2009]
(اضطرابات التخثر وجلطات الدم فى سرطان الأطفال)
دكتوراه فى طب الاطفال, -جامعة الزقازيق [2014]
(اثر النمط الجيني علي مضاعفات الغدد الصماء في مرضى انيميا البحر المتوسط)

الحالة الوظيفية الحالية :

قائم بالعمل

التدرج الوظيفى الأكاديمى

معيد : 27/7/2009
مدرس مساعد : 31/10/2009
مدرس : 29/4/2014
أستاذ مساعد : 28/5/2019

الأبحاث العلمية

1 - First Report of Acute Lymphoblastic Leukemia in an Egyptian Child with b-Thalassemia Major (1436).

2 - Renal Presentation in Pediatric Acute Leukemia Report of 2 Cases (1436).

3 - Target Therapy in Neuroblastoma (1439).

4 - CHANGE IN IMMUNOLOGICAL MEMORY OF HEPATITIS B VACCINE AFTER CHEMOTHERAPY; A REAL PROBLEM IN PEDIATRIC CANCER PATIENTS (1437).

5 - Evaluation of the Immune Response to Interferon Gamma Release Assay and Tuberculin Skin Test Among BCG Vaccinated Children in East of Egypt A Cross-Sectional Study (1437).

6 - Status of serum magnesium in Egyptian children with type 1 diabetes and its correlation to glycemic control and lipid profile (1437).

7 - Impact of iron deﬁciency anemia on the function of the immune system in children (1437).

8 - Effect of breastfeeding versus infant formula on iron status of infants with beta thalassemia major (1438).

9 - Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies (1439).

10 - Impact of genotype of beta globin gene on hepatic and myocardial iron content in Egyptian patients with beta thalassemia (1440).

11 - Association between genotype and disease complications in Egyptian patients with beta thalassemia: A Cross-sectional study (1440).

12 - Chemotherapy‑induced neutropenia among pediatric cancer patients in Egypt: Risks and consequences (1437).

13 - Impact of genotype on endocrinal complications in β‑thalassemia patients (1437).

14 - Cluster of differentiation 97 as a biomarker for the detection of minimal residual disease in common acute lymphoblastic leukemia (1438).

15 - Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor-1 and osteonecrosis risk in childhood acute lymphoblastic leukemia (1442).

16 - FcgRIIa and FcgRIIIa genes polymorphism in Egyptian children with primary immune thrombocytopenia (1442).

17 - Cerebral sinuses thrombosis prior to the diagnosis of acute lymphoblastic leukemia in a child: A case report (1444).

18 - Assessment of serum aflatoxin B1 levels in neonatal jaundice with glucose 6 phosphate dehydrogenase defciency: a preliminary study (1442).

19 - PTPN22 gene polymorphism as a genetic risk factor for primary immune thrombocytopenia in Egyptian children (1443).

20 - Serum endocan and endothelial dysfunction in childhood acute lymphoblastic leukemia survivors: a tertiary center experience (1442).

21 - Contribution of interleukin 27 serum level to pathogenesis and prognosis in children with immune thrombocytopenia (1443).

22 - Association between ATP binding cassette gene member 1 polymorphism and glucocorticoid response in children with immune thrombocytopenia (1443).

23 - Role of serum cystatin C in the prediction of acute kidney injury following pediatric cardiac surgeries A single center experience (1444).

24 - Role of interleukin 4 (IL4) and interleukin 6 (IL6) in the pathogenesis and prognosis of childhood primary immune thrombocytopenia (1444).

25 - Contribution of T helper 17 cells and interleukin 17 to the pathogenesis of primary immune thrombocytopenia in Egyptian children (1445).

26 - Tissue factor expression predicts outcome in children with neuroblastoma: A retrospective stud (1441).

27 - Subclinical nephrotoxicity in patients with beta-thalassemia: role of urinary kidney injury molecule (1441).

28 - Transfusion of blood components in pediatric age groups: an evidence-based clinical practice guideline adapted for the use in Egypt using ‘Adapted ADAPTE’ (1445).

29 - Diagnosis, management and prevention of Pediatric Acute Hemolytic Anemia: Egyptian adapted evidence-based clinical practice guidelines (1445).

30 - Place of Emicizumab in the Management of Hemophilia A: Review Article (1444).

31 - HEMOCHROMATOSIS HFE GENE POLYMORPHISM AND DEVELOPMENT OF PREDIABETES AND DIABETES MELLITUS IN B THALASSEMIC PATIENTS (1443).

32 - Prevalence of Acute Kidney Injury in Pediatric Patients with Congenital Heart Disease Following Open Heart Surgery (1442).

33 - Association Between BAFF Gene Polymorphism And Clinical course of Newly Diagnosed Immune Thrombocytopenic Purpura In Children (1441).

34 - Efficacy and Safety of Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura in Children and Adolescents (1441).

35 - Deviation from Guidelines in Use of Eltrombopag and Romiplostim in Clinical Practice for Children with Primary Immune Thrombocytopenia; Multi-Center Egyptian Experience (1441).

36 - Prevalence, Prognosis, and Outcome in Egyptian Children with Primary Immune Thrombocytopenia: A Single-Center Experience (1443).

37 - Vitamin D Status and Risk of Osteoporosis in Hemophilia Patients (1443).

38 - • Ocular radiological findings in Children with Acute Lymphoblastic Leukemia: a cross sectional study (1444).

39 - A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events (1437).

40 - .Can CD34/CD123 distinguish between normal and leukemic B-cell precursors (1439).

المجالات البحثية

طب الاطفال